Drug Type Gene therapy |
Synonyms + [1] |
Target |
Action modulators, stimulants |
Mechanism BTK modulators(Tyrosine-protein kinase BTK modulators), Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bruton Type Agammaglobulinemia | Preclinical | Israel | 01 Feb 2025 |